Texas Permanent School Fund boosted its stake in shares of Cutera, Inc. (NASDAQ:CUTR – Get Rating) by 3.1% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 11,946 shares of the medical device company’s stock after acquiring an additional 361 shares during the quarter. Texas Permanent School Fund’s holdings in Cutera were worth $448,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. Cowen AND Company LLC acquired a new stake in shares of Cutera during the second quarter worth about $22,361,000. Loomis Sayles & Co. L P acquired a new stake in shares of Cutera during the second quarter worth about $12,309,000. Emerald Advisers LLC lifted its position in shares of Cutera by 64.9% during the second quarter. Emerald Advisers LLC now owns 460,232 shares of the medical device company’s stock worth $17,259,000 after purchasing an additional 181,197 shares in the last quarter. Emerald Mutual Fund Advisers Trust lifted its position in shares of Cutera by 66.8% during the second quarter. Emerald Mutual Fund Advisers Trust now owns 385,744 shares of the medical device company’s stock worth $14,465,000 after purchasing an additional 154,504 shares in the last quarter. Finally, RTW Investments LP lifted its position in shares of Cutera by 9.2% during the first quarter. RTW Investments LP now owns 1,526,263 shares of the medical device company’s stock worth $105,312,000 after purchasing an additional 129,200 shares in the last quarter.
Analysts Set New Price Targets
CUTR has been the topic of several research reports. Stephens initiated coverage on shares of Cutera in a research report on Thursday, October 13th. They set an “overweight” rating and a $78.00 price target on the stock. Piper Sandler reduced their target price on shares of Cutera from $65.00 to $55.00 and set an “overweight” rating on the stock in a report on Friday, August 5th. Maxim Group reaffirmed a “buy” rating and issued a $80.00 target price on shares of Cutera in a report on Friday, August 5th. Finally, StockNews.com started coverage on shares of Cutera in a report on Wednesday, October 12th. They issued a “sell” rating on the stock. One research analyst has rated the stock with a sell rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $70.75.
Cutera Stock Down 0.8 %
Cutera, Inc, a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis.
- Get a free copy of the StockNews.com research report on Cutera (CUTR)
- After Nixing its 13% Dividend, Is Lumen Technologies Okay To Own?
- The Sell-Side Caps Gains In Dick’s Sporting Goods
- Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
- Stock-ing Stuffers: 3 Attractive Stocks Trading Around $10
- Want to Get a 10% Dividend Yield, Look Here
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.